Safety and Efficacy of Na Alginate and Mesna in Endoscopic Submucosal Dissection: A Systematic Review and Meta-analysis
ASIDE GI Issue 2
PDF
Supplementary File

Keywords

Mesna
Endoscopic Submucosal Dissection
Sodium Alginate
Na alginate

How to Cite

1.
Abosheaishaa H, Abdallfatah A, Samman Tahhan I, et al. Safety and Efficacy of Na Alginate and Mesna in Endoscopic Submucosal Dissection: A Systematic Review and Meta-analysis. ASIDE GI. 2025;1(2):10-15. doi:10.71079/ASIDE.GI.04222537

Funding data

Abstract

Background: Sodium hyaluronate, commonly used in ESD, has drawbacks such as high cost and potential tumorigenesis. Sodium alginate (Na alginate) and Mesna offer promising alternative solutions with their viscoelastic and mucolytic properties. In this review we aimed to evaluate the safety and efficacy of Na alginate and Mesna solutions in ESD.

Methods: A systematic search was conducted across multiple databases. Inclusion criteria were randomized controlled trials and observational studies assessing Na alginate and Mesna in ESD. Primary outcome included en-bloc resection rates. Secondary outcomes included adverse events such as perforation and delayed bleeding, and procedural time.

Results: Eight studies involving 255 patients were included in this analysis. Overall en-bloc resection rate for sodium alginate was 97% [95% CI (93%-99%); I2:0%]. En-bloc resection subgroup analysis revealed 97% [95% CI (93%-99%); I2:0%] for 0.6% sodium alginate and 95% [95% CI (70%-99%); I2: 0%] for 0.4% sodium alginate. Moreover, En-bloc resection rate for Mesna was 98% [95%CI: 92%-100%); I2: 0%]. Delayed bleeding rates for sodium alginate were 5% [95% CI (1%-20%); I2: 65.2%]; however, after subgroup analysis delayed bleeding was 2% [95% CI (1%-6%); I2: 0%] for 0.6% sodium alginate and 22% [95% CI (8%-49%); I2:0%] for 0.4% sodium alginate. Perforation rate for 0.6% sodium alginate was 1% [95% CI (0%-5%); I2: 0%].

Conclusion: Na alginate (0.6%) and Mesna are effective and safe alternatives to sodium hyaluronate for submucosal injection in ESD. These solutions offer potential cost-effective and safer options for clinical practice, with Na alginate (0.6%) showing particularly low adverse event rates.

PDF
Supplementary File

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021: 209 [PMID: 33538338, https://doi.org/10.3322/caac.21660]

2. Taylor PR, Abnet CC, Dawsey SM. Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013: 540 [PMID: 23549398, https://doi.org/10.1158/1055-9965.EPI-12-1347]

3. Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy. 2009: 751 [PMID: 19693750, https://doi.org/10.1055/s-0029-1215053]

4. Higuchi K, Tanabe S, Azuma M, Katada C, Sasaki T, Ishido K, Naruke A, Katada N, Koizumi W. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc. 2013: 704 [PMID: 23680178, https://doi.org/10.1016/j.gie.2013.04.182]

5. Isomoto H, Yamaguchi N, Minami H, Nakao K. Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer. Dig Endosc. 2013: 29 [PMID: 23368404, https://doi.org/10.1111/j.1443-1661.2012.01388.x]

6. Castro R, Libanio D, Pita I, Dinis-Ribeiro M. Solutions for submucosal injection: What to choose and how to do it. World J Gastroenterol. 2019: 777 [PMID: 30809079, https://doi.org/10.3748/wjg.v25.i7.777]

7. Jung YS, Park DI. Submucosal injection solutions for endoscopic mucosal resection and endoscopic submucosal dissection of gastrointestinal neoplasms. Gastrointestinal Intervention. 2013: 73 https://doi.org/10.1016/j.gii.2013.09.003]

8. Uraoka T, Saito Y, Yamamoto K, Fujii T. Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection. Drug Des Devel Ther. 2009: 131 [PMID: 19920900, https://doi.org/10.2147/dddt.s3219]

9. Matsui Y, Inomata M, Izumi K, Sonoda K, Shiraishi N, Kitano S. Hyaluronic acid stimulates tumor-cell proliferation at wound sites. Gastrointest Endosc. 2004: 539 [PMID: 15472675, https://doi.org/10.1016/s0016-5107(04)01890-5]

10. Benassi L, Benassi G, Kaihura CT, Marconi L, Ricci L, Vadora E. Chemically assisted dissection of tissues in laparoscopic excision of endometriotic cysts. J Am Assoc Gynecol Laparosc. 2003: 205 [PMID: 12732773, https://doi.org/10.1016/s1074-3804(05)60300-3]

11. Benassi L, Lopopolo G, Pazzoni F, Ricci L, Kaihura C, Piazza F, Vadora E, Zini C. Chemically assisted dissection of tissues: an interesting support in abdominal myomectomy. J Am Coll Surg. 2000: 65 [PMID: 10898185, https://doi.org/10.1016/s1072-7515(00)00296-9]

12. Denaro V, Di Martino A, Longo UG, Costa V, Papalia R, Forriol F, Denaro L. Effectiveness of a mucolythic agent as a local adjuvant in revision lumbar spine surgery. Eur Spine J. 2008: 1752 [PMID: 18839224, https://doi.org/10.1007/s00586-008-0802-y]

13. Reinhart WH, Baerlocher GM, Cerny T, Owen GR, Meiselman HJ, Beer JH. Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood. Eur J Haematol. 1999: 223 [PMID: 10227455, https://doi.org/10.1111/j.1600-0609.1999.tb01751.x]

14. Vincenti V, Mondain M, Pasanisi E, Piazza F, Puel JL, Bacciu S, Quaranta N, Uziel A, Zini C. Cochlear effects of mesna application into the middle ear. Ann N Y Acad Sci. 1999: 425 [PMID: 10842611, https://doi.org/10.1111/j.1749-6632.1999.tb08659.x]

15. Daigo K, Wada Y, Yamada C, Yamaji M, Okuda S, Okada M, Miyazato T. [Pharmacological studies of sodium alginate. I. Protective effect of sodium alginate on mucous membranes of upper-gastrointestinal tract]. Yakugaku Zasshi. 1981: 452 [PMID: 6793708, https://doi.org/10.1248/yakushi1947.101.5_452]

16. Diago K, Yamada C, Yamaji M, Nakagiri N, Okada M, Komiya H, Horiuchi Y, Miyazato T. [Pharmacological studies of sodium alginate. V. Effect of sodium alginate on platelet aggregation]. Yakugaku Zasshi. 1985: 171 [PMID: 4009424, https://doi.org/10.1248/yakushi1947.105.2_171]

17. Daigo K, Yamaji M, Yamada C, Wada Y, Okuda S, Okada M, Miyazato T. [Pharmacological studies of sodium alginate. III. Acceleration of fibrin formation by sodium alginate]. Yakugaku Zasshi. 1981: 464 [PMID: 7288587, https://doi.org/10.1248/yakushi1947.101.5_464]

18. Daigo K, Yamada C, Wada Y, Yamaji M, Okuda S, Okada M, Miyazato T. [Pharmacological studies of sodium alginate. II. Hemostatic effect of sodium alginate on gastrointestinal bleeding]. Yakugaku Zasshi. 1981: 458 [PMID: 6974775, https://doi.org/10.1248/yakushi1947.101.5_458]

19. Uemura N, Oda I, Saito Y, Ono H, Fujisaki J, Matsuhashi N, Ohata K, Yahagi N, Yada T, Satoh M, Tajiri H, Inomata M, Kitano S. Efficacy and safety of 0.6% sodium alginate solution in endoscopic submucosal dissection for esophageal and gastric neoplastic lesion: A randomized controlled study. Dig Endosc. 2019: 396 [PMID: 30667557, https://doi.org/10.1111/den.13352]

20. Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019: ED000142 [PMID: 31643080, https://doi.org/10.1002/14651858.ED000142]

21. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010: 336 [PMID: 20171303, https://doi.org/10.1016/j.ijsu.2010.02.007]

22. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016: i4919 [PMID: 27733354, https://doi.org/10.1136/bmj.i4919]

23. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernan MA, Hopewell S, Hrobjartsson A, Junqueira DR, Juni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019: l4898 [PMID: 31462531, https://doi.org/10.1136/bmj.l4898]

24. Wallace BC, Lajeunesse MJ, Dietz G, Dahabreh IJ, Trikalinos TA, Schmid CH, Gurevitch J, Poisot T. OpenMEE: Intuitive, open‐source software for meta‐analysis in ecology and evolutionary biology. Methods in Ecology and Evolution. 2017: 941 https://doi.org/10.1111/2041-210x.12708]

25. Akagi T, Yasuda K, Tajima M, Suzuki K, Inomata M, Shiraishi N, Sato Y, Kitano S. Sodium alginate as an ideal submucosal injection material for endoscopic submucosal resection: preliminary experimental and clinical study. Gastrointest Endosc. 2011: 1026 [PMID: 22032316, https://doi.org/10.1016/j.gie.2011.07.042]

26. Dobashi A, Goda K, Sumiyama K, Kobayashi M, Ohya TR, Kato M, Toyoizumi H, Kato T, Matsushima M, Tajiri H. A feasibility study of chemically assisted endoscopic submucosal mechanical dissection using mesna for superficial esophageal squamous cell carcinomas. Surg Endosc. 2015: 3373 [PMID: 25515984, https://doi.org/10.1007/s00464-014-4031-7]

27. Kang JW, Chen PJ, Chen CY, Riley G, Wang YS, Kuo HY, Chuang CH. Development of a hybrid hydrogel for submucosal injection in endoscopic resection of gastrointestinal neoplasm: From laboratory to clinical trial. Endosc Int Open. 2023: E1026 [PMID: 38835638, https://doi.org/10.1055/a-2161-2100]

28. Kusano T, Etoh T, Akagi T, Ueda Y, Shiroshita H, Yasuda K, Satoh M, Inomata M, Shiraishi N, Kitano S. Evaluation of 0.6% sodium alginate as a submucosal injection material in endoscopic submucosal dissection for early gastric cancer. Dig Endosc. 2014: 638 [PMID: 24655031, https://doi.org/10.1111/den.12268]

29. Nakamura H, Morita R, Ito R, Sakurada A, Tomita N, Hirata Y, Kanari Y, Komatsu Y, Takanashi K, Anbo T, Katsuki S. Feasibility and safety of 0.6% sodium alginate in endoscopic submucosal dissection for colorectal neoplastic lesion: A pilot study. DEN Open. 2024: e313 [PMID: 37927953, https://doi.org/10.1002/deo2.313]

30. Sumiyama K, Tajiri H, Gostout CJ, Kawamura M, Imazu H, Ohya TR, Ikeda K, Goda K, Saito S, Kato T. Chemically assisted submucosal injection facilitates endoscopic submucosal dissection of gastric neoplasms. Endoscopy. 2010: 627 [PMID: 20552541, https://doi.org/10.1055/s-0029-1244223]

31. Sumiyama K, Toyoizumi H, Ohya TR, Dobashi A, Hino S, Kobayashi M, Goda K, Imazu H, Kawakita Y, Kato T, Tajiri H. A double-blind, block-randomized, placebo-controlled trial to identify the chemical assistance effect of mesna submucosal injection for gastric endoscopic submucosal dissection. Gastrointest Endosc. 2014: 756 [PMID: 24238308, https://doi.org/10.1016/j.gie.2013.09.027]

32. Iwashita C, Sakamoto H, Miura Y, Shinozaki S, Hayashi Y, Ino Y, Osawa H, Tamba M, Morita K, Lefor AK, Yamamoto H. Esophageal endoscopic submucosal dissection using sodium hyaluronate is safe and effective. Minim Invasive Ther Allied Technol. 2018: 171 [PMID: 28749205, https://doi.org/10.1080/13645706.2017.1356735]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 ASIDE Gastroenterology